Analgesics in Russia

Date: October 20, 2017
Pages: 13
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AC0C3D64182EN
Leaflet:

Download PDF Leaflet

As the majority of analgesics are included on the state list of vital and essential medicines, their unit prices are regulated by the state. Manufacturers and sellers do not have the right to set a unit price higher than that established and approved by the government. The list of vital and essential medicines is updated every year. Analgesics which fell under these regulations in 2017 included acetaminophen, aspirin, diclofenac and ibuprofen. State regulation of unit prices discourages manufact...

Euromonitor International's Analgesics in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Government Unit Price Regulations on Vital and Essential Medicines Serve To Limit Value Growth
Topical Analgesics/anaesthetic the Best Performer in 2017
Competitive Landscape
Analgesics in Russia Remains Consolidated in 2017
Increasing Awareness of Generics Poses A Threat To Brands
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Demand for Consumer Health Products Recovers Amidst the Economic Recession
Russian Consumer Health Slowly Adapts To Changing Conditions
Consumer Health Hampered by the Wide Use of Raw Herbal Materials and the Increasing Share of Generics
Russian Demographics Shape the Performance of Consumer Health
Consumer Health Expected To Grow at A Slow Pace Over the Forecast Period
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
  Summary 1 Research Sources
Skip to top


OTC Pharmaceuticals in Russia US$ 350.00 Sep, 2016 · 34 pages
Adult Mouth Care in Russia US$ 990.00 Sep, 2016 · 30 pages

Ask Your Question

Analgesics in Russia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: